ConvaTec Aktie

2,46EUR -0,02EUR -0,81%
ConvaTec für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2AUD3 / ISIN: GB00BD3VFW73

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 10 142 10 036 10 136 10 489 10 910
Umsatz pro Mitarbeiter in Mio. EUR 0,15 0,17 0,17 0,17 0,17

Bilanz (in Mio. GBP) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 820 739 682 633 699
Summe Anlagevermögen 1 892 2 247 2 231 2 173 2 112
Summe Aktiva 2 713 2 986 2 913 2 807 2 811

Bilanz (in Mio. GBP) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 1 461 1 648 1 585 1 458 1 682
Summe Eigenkapital 1 251 1 338 1 328 1 349 1 129
Summe Passiva 2 713 2 986 2 913 2 807 2 811

Adresse

20 Eastbourne Terrace, W2 6LG London
Telefon +44 (11) 89528100
Internet http://www.convatecgroup.com

Management

Brian Michael May
Independent Non-Executive Director
Clare Holden
Chief Quality & Regulatory Affairs Officer
David Phillips
Treasury & Head-Investor Relations
David Shepherd
Chief Commercial Officer
Emma Rose
Chief People Officer & Executive Vice President
Evelyn Douglas
Chief Strategy & Business Development Officer
Fiona Victoria Ryder
CFO, Director & Financial Controller
Heather Lynn Mason
Independent Non-Executive Director
James Edward Spencer Kerton
Secretary, General Counsel & Executive VP
John David Gibson McAdam
Chairman
Jonathan Peter Mason
Chief Executive Officer & Director
Kimberly Sue Lody
Independent Non-Executive Director
Kjersti Grimsrud
President-Infusion Care
Margaret Ewing
Senior Independent Non-Executive Director
Neal Carty
Chief Science & Innovation Officer
Peter Jarvis
Chief Operations Officer
Sharon L. O'Keefe
Independent Non-Executive Director